Novartis Says Docs Request In $3.3B FCA Suit Is Too Late
The whistleblower bringing a $3.35 billion False Claims Act case against Novartis Pharmaceutical Corp. should not be granted access to more employee files than he already has been, as he had...To view the full article, register now.
Already a subscriber? Click here to view full article